arrow
J

John W. Upham

the university of queensland
H指数:60
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Real-World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe Asthma

一项真实世界多中心对照研究,评估苯瑞利珠单抗治疗与重度哮喘主要结局的关联

2026-05-270
OAAI
Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry

Mepolizumab治疗和减少口服糖皮质激素暴露可改善重症嗜酸性哮喘患者的抑郁和焦虑症状:来自澳大利亚Mepolizumab登记研究的数据

2025-09-010
PRE
Association between hospitalised childhood pneumonia and follow-up chest radiographs in high-risk populations: a secondary analysis of a multicentre randomised controlled trial

高风险人群中住院儿童肺炎与随访胸部X光片的关联:一项多中心随机对照试验的二次分析

2025-05-090
PRE
Impact of Biologics Initiation on Oral Corticosteroid Use in the International Severe Asthma Registry and the Optimum Patient Care Research Database: A Pooled Analysis of Real-World Data

生物制剂启动对口服糖皮质激素使用的影响:国际重症哮喘注册登记研究与国际患者护理研究数据库的真实世界数据合并分析

2025-04-260
OAAI
Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults

成人重症哮喘生物治疗后临床缓解的定义和预测因素探讨

2024-10-018
OAAI
Exploring Definitions and Predictors of Response to Biologics for Severe Asthma
2024-09-018
OAAI
Real-world biologics response and super-response in the International Severe Asthma Registry cohort

国际重症哮喘登记队列中的真实世界生物制剂反应和超反应

2024-06-220
OAAI
Effect of add-on therapies (mepolizumab, omalizumab or azithromycin) on asthma remission in severe asthma
2023-10-270
PRE
Impact of Landscape Fire Smoke Exposure on Patients With Asthma With or Without Laryngeal Hypersensitivity

景观火灾烟雾暴露对有或没有喉部超敏反应的哮喘患者的影响

2023-10-015
PRE
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients

生物制剂 (美泊利单抗和奥马珠单抗) 诱导重症哮喘患者的缓解

2023-08-2514
OA
Maternal diet modulates the infant microbiome and intestinal Flt3L necessary for dendritic cell development and immunity to respiratory infection
IMMUNITY
IF26.3
2023-05-0124
OA